0
     

Report Added
Report already added
Peptic Ulcer Drugs Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Peptic Ulcer Drugs Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

A peptic ulcer is a round or oval sore where the lining of the stomach or duodenum has been eaten away by stomach acid and digestive juices. Peptic ulcers can result from helicobacter pylori infection or from drugs that weaken the lining of the stomach or duodenum. This report mainly studies peptic ulcer drugs market._x000D_
_x000D_
This report contains market size and forecasts of Peptic Ulcer Drugs in India, including the following market information:_x000D_
India Peptic Ulcer Drugs Market Revenue, 2015-2020, 2021-2026, ($ millions)_x000D_
India Peptic Ulcer Drugs Market Consumption, 2015-2020, 2021-2026, (M Unit)_x000D_
India Peptic Ulcer Drugs Production Capacity, 2015-2020, 2021-2026, (M Unit)_x000D_
Top Five Competitors in India Peptic Ulcer Drugs Market 2019 (%)_x000D_
The global Peptic Ulcer Drugs market was valued at 16580 million in 2019 and is projected to reach US$ 19130 million by 2026, at a CAGR of 3.6% during the forecast period. While the Peptic Ulcer Drugs market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026._x000D_
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptic Ulcer Drugs manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas._x000D_
This report also analyses and evaluates the COVID-19 impact on Peptic Ulcer Drugs production and consumption in India_x000D_
Total Market by Segment:_x000D_
India Peptic Ulcer Drugs Market, By Type, 2015-2020, 2021-2026 ($ millions) & (M Unit)_x000D_
India Peptic Ulcer Drugs Market Segment Percentages, By Type, 2019 (%)_x000D_
Proton Pump Inhibitors_x000D_
Antacids_x000D_
H2-Antagonists_x000D_
Others_x000D_
Proton pump inhibitors segment was estimated to account for a revenue share of 75.6% in 2019._x000D_
_x000D_
India Peptic Ulcer Drugs Market, By Application, 2015-2020, 2021-2026 ($ millions) & (M Unit)_x000D_
India Peptic Ulcer Drugs Market Segment Percentages, By Application, 2019 (%)_x000D_
Hospital and Clinic_x000D_
Drugstore_x000D_
Hospital and clinic segment was estimated to account for a sales share of 75.7% in 2019._x000D_
_x000D_
Competitor Analysis_x000D_
The report also provides analysis of leading market participants including:_x000D_
Total Peptic Ulcer Drugs Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)_x000D_
Total Peptic Ulcer Drugs Market Competitors Revenues Share in India, by Players 2019 (%)_x000D_
Total India Peptic Ulcer Drugs Market Competitors Sales, by Players 2015-2020 (Estimated), (M Unit)_x000D_
Total India Peptic Ulcer Drugs Market Competitors Sales Market Share by Players 2019 ($ millions)_x000D_
Further, the report presents profiles of competitors in the market, including the following:_x000D_
Takeda Pharmaceutical_x000D_
AstraZeneca_x000D_
Pfizer_x000D_
Teva Pharmaceuticals_x000D_
EA Pharma_x000D_
ASK Pharm_x000D_
Luoxin Pharmaceutical_x000D_
Abbott Laboratories_x000D_
Yuhan Pharmaceutical_x000D_
1 Introduction to Research & Analysis Reports_x000D_
1.1 Peptic Ulcer Drugs Market Definition_x000D_
1.2 Market Segments_x000D_
1.2.1 Segment by Type_x000D_
1.2.2 Segment by Application_x000D_
1.3 India Peptic Ulcer Drugs Market Overview_x000D_
1.4 Features & Benefits of This Report_x000D_
1.5 Methodology & Sources of Information_x000D_
1.5.1 Research Methodology_x000D_
1.5.2 Research Process_x000D_
1.5.3 Base Year_x000D_
1.5.4 Report Assumptions & Caveats_x000D_
_x000D_
2 COVID-19 Impact: India Peptic Ulcer Drugs Overall Market Size_x000D_
2.1 India Peptic Ulcer Drugs Market Size: 2020 VS 2026_x000D_
2.2 India Peptic Ulcer Drugs Revenue, Prospects & Forecasts: 2015-2026_x000D_
2.3 India Peptic Ulcer Drugs Sales (Consumption): 2015-2026_x000D_
_x000D_
3 Company Landscape_x000D_
3.1 Top Peptic Ulcer Drugs Players in India (including Foreign and Local Companies)_x000D_
3.2 Top India Peptic Ulcer Drugs Companies Ranked by Revenue_x000D_
3.3 India Peptic Ulcer Drugs Revenue by Companies (including Foreign and Local Companies)_x000D_
3.4 India Peptic Ulcer Drugs Sales by Companies (including Foreign and Local Companies)_x000D_
3.5 India Peptic Ulcer Drugs Price by Manufacturer (2015-2020)_x000D_
3.6 Top 3 and Top 5 Peptic Ulcer Drugs Companies in India, by Revenue in 2019_x000D_
3.7 India Manufacturers Peptic Ulcer Drugs Product Type_x000D_
3.8 Tier 1, Tier 2 and Tier 3 Peptic Ulcer Drugs Players in India_x000D_
3.8.1 List of India Tier 1 Peptic Ulcer Drugs Companies_x000D_
3.8.2 List of India Tier 2 and Tier 3 Peptic Ulcer Drugs Companies_x000D_
_x000D_
4 Sights by Product_x000D_
4.1 Overview_x000D_
4.1.1 By Type - India Peptic Ulcer Drugs Market Size Markets, 2020 & 2026_x000D_
4.1.2 Proton Pump Inhibitors_x000D_
4.1.3 Antacids_x000D_
4.1.4 H2-Antagonists_x000D_
4.1.5 Others_x000D_
4.2 By Type - India Peptic Ulcer Drugs Revenue & Forecasts_x000D_
4.2.1 By Type - India Peptic Ulcer Drugs Revenue, 2015-2020_x000D_
4.2.2 By Type - India Peptic Ulcer Drugs Revenue, 2021-2026_x000D_
4.2.3 By Type - India Peptic Ulcer Drugs Revenue Market Share, 2015-2026_x000D_
4.3 By Type - India Peptic Ulcer Drugs Sales & Forecasts_x000D_
4.3.1 By Type - India Peptic Ulcer Drugs Sales, 2015-2020_x000D_
4.3.2 By Type - India Peptic Ulcer Drugs Sales, 2021-2026_x000D_
4.3.3 By Type - India Peptic Ulcer Drugs Sales Market Share, 2015-2026_x000D_
4.4 By Type - India Peptic Ulcer Drugs Price (Manufacturers Selling Prices), 2015-2026_x000D_
5 Sights by Application_x000D_
5.1 Overview_x000D_
5.1.1 By Application - India Peptic Ulcer Drugs Market Size, 2020 & 2026_x000D_
5.1.2 Hospital and Clinic_x000D_
5.1.3 Drugstore_x000D_
5.2 By Application - India Peptic Ulcer Drugs Revenue & Forecasts_x000D_
5.2.1 By Application - India Peptic Ulcer Drugs Revenue, 2015-2020_x000D_
5.2.2 By Application - India Peptic Ulcer Drugs Revenue, 2021-2026_x000D_
5.2.3 By Application - India Peptic Ulcer Drugs Revenue Market Share, 2015-2026_x000D_
5.3 By Application - India Peptic Ulcer Drugs Sales & Forecasts_x000D_
5.3.1 By Application - India Peptic Ulcer Drugs Sales, 2015-2020_x000D_
5.3.2 By Application - India Peptic Ulcer Drugs Sales, 2021-2026_x000D_
5.3.3 By Application - India Peptic Ulcer Drugs Sales Market Share, 2015-2026_x000D_
5.4 By Application - India Peptic Ulcer Drugs Price (Manufacturers Selling Prices), 2015-2026_x000D_
6 Manufacturers & Brands Profiles_x000D_
6.1 Takeda Pharmaceutical_x000D_
6.1.1 Takeda Pharmaceutical Corporate Summary_x000D_
6.1.2 Takeda Pharmaceutical Business Overview_x000D_
6.1.3 Takeda Pharmaceutical Peptic Ulcer Drugs Major Product Offerings_x000D_
6.1.4 Takeda Pharmaceutical Sales and Revenue in India (2015-2020)_x000D_
6.1.5 Takeda Pharmaceutical Key News_x000D_
6.2 AstraZeneca_x000D_
6.2.1 AstraZeneca Corporate Summary_x000D_
6.2.2 AstraZeneca Business Overview_x000D_
6.2.3 AstraZeneca Peptic Ulcer Drugs Major Product Offerings_x000D_
6.2.4 AstraZeneca Sales and Revenue in India (2015-2020)_x000D_
6.2.5 AstraZeneca Key News_x000D_
6.3 Pfizer_x000D_
6.3.1 Pfizer Corporate Summary_x000D_
6.3.2 Pfizer Business Overview_x000D_
6.3.3 Pfizer Peptic Ulcer Drugs Major Product Offerings_x000D_
6.3.4 Pfizer Sales and Revenue in India (2015-2020)_x000D_
6.3.5 Pfizer Key News_x000D_
6.4 Teva Pharmaceuticals_x000D_
6.4.1 Teva Pharmaceuticals Corporate Summary_x000D_
6.4.2 Teva Pharmaceuticals Business Overview_x000D_
6.4.3 Teva Pharmaceuticals Peptic Ulcer Drugs Major Product Offerings_x000D_
6.4.4 Teva Pharmaceuticals Sales and Revenue in India (2015-2020)_x000D_
6.4.5 Teva Pharmaceuticals Key News_x000D_
6.5 EA Pharma_x000D_
6.5.1 EA Pharma Corporate Summary_x000D_
6.5.2 EA Pharma Business Overview_x000D_
6.5.3 EA Pharma Peptic Ulcer Drugs Major Product Offerings_x000D_
6.5.4 EA Pharma Sales and Revenue in India (2015-2020)_x000D_
6.5.5 EA Pharma Key News_x000D_
6.6 ASK Pharm_x000D_
6.6.1 ASK Pharm Corporate Summary_x000D_
6.6.2 ASK Pharm Business Overview_x000D_
6.6.3 ASK Pharm Peptic Ulcer Drugs Major Product Offerings_x000D_
6.6.4 ASK Pharm Sales and Revenue in India (2015-2020)_x000D_
6.6.5 ASK Pharm Key News_x000D_
6.7 Luoxin Pharmaceutical_x000D_
6.6.1 Luoxin Pharmaceutical Corporate Summary_x000D_
6.6.2 Luoxin Pharmaceutical Business Overview_x000D_
6.6.3 Luoxin Pharmaceutical Peptic Ulcer Drugs Major Product Offerings_x000D_
6.4.4 Luoxin Pharmaceutical Sales and Revenue in India (2015-2020)_x000D_
6.7.5 Luoxin Pharmaceutical Key News_x000D_
6.8 Abbott Laboratories_x000D_
6.8.1 Abbott Laboratories Corporate Summary_x000D_
6.8.2 Abbott Laboratories Business Overview_x000D_
6.8.3 Abbott Laboratories Peptic Ulcer Drugs Major Product Offerings_x000D_
6.8.4 Abbott Laboratories Sales and Revenue in India (2015-2020)_x000D_
6.8.5 Abbott Laboratories Key News_x000D_
6.9 Yuhan Pharmaceutical_x000D_
6.9.1 Yuhan Pharmaceutical Corporate Summary_x000D_
6.9.2 Yuhan Pharmaceutical Business Overview_x000D_
6.9.3 Yuhan Pharmaceutical Peptic Ulcer Drugs Major Product Offerings_x000D_
6.9.4 Yuhan Pharmaceutical Sales and Revenue in India (2015-2020)_x000D_
6.9.5 Yuhan Pharmaceutical Key News_x000D_
6.10 Daewoong Pharmaceutical_x000D_
6.10.1 Daewoong Pharmaceutical Corporate Summary_x000D_
6.10.2 Daewoong Pharmaceutical Business Overview_x000D_
6.10.3 Daewoong Pharmaceutical Peptic Ulcer Drugs Major Product Offerings_x000D_
6.10.4 Daewoong Pharmaceutical Sales and Revenue in India (2015-2020)_x000D_
6.10.5 Daewoong Pharmaceutical Key News_x000D_
_x000D_
7 Peptic Ulcer Drugs Production Capacity, Export and Import Analysis_x000D_
7.1 Peptic Ulcer Drugs Production Capacity and Value in India, Situation Analysis and Prediction, 2015-2026_x000D_
7.1.1 India Peptic Ulcer Drugs Production Capacity, 2015-2026_x000D_
7.1.2 India Peptic Ulcer Drugs Production 2015-2026_x000D_
7.1.3 India Peptic Ulcer Drugs Production Value 2015-2026_x000D_
7.2 Key Local Peptic Ulcer Drugs Manufacturers in India_x000D_
7.2.1 India Key Local Peptic Ulcer Drugs Manufacturers Production Capacity_x000D_
7.2.2 India Key Local Peptic Ulcer Drugs Manufacturers Production_x000D_
7.2.3 India Key Local Peptic Ulcer Drugs Manufacturers Production Value_x000D_
7.2.4 The Proportion of Peptic Ulcer Drugs Production Sold in India and Sold Other Than India by Manufacturers_x000D_
7.3 Peptic Ulcer Drugs Export and Import in India_x000D_
7.3.1 India Peptic Ulcer Drugs Export Market_x000D_
7.3.2 India Peptic Ulcer Drugs Source of Imports_x000D_
_x000D_
8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints_x000D_
8.1 PESTLE Analysis for India Peptic Ulcer Drugs Market_x000D_
8.2 Market Opportunities & Trends_x000D_
8.3 Market Drivers_x000D_
8.4 Market Restraints_x000D_
_x000D_
9 COVID-19 Impact on Peptic Ulcer Drugs Supply Chain Analysis_x000D_
9.1 Supply Chain Analysis_x000D_
9.2 Upstream Market Analysis_x000D_
9.3 Downstream and Clients Market Analysis_x000D_
9.4 Marketing Channels Analysis_x000D_
9.4.1 Marketing Channels_x000D_
9.4.2 Peptic Ulcer Drugs Distributors and Sales Agents in India_x000D_
_x000D_
10 Conclusion_x000D_
_x000D_
11 Appendix_x000D_
11.1 Note_x000D_
11.2 Examples of Clients_x000D_
11.3 Disclaimer_x000D_
List of Tables_x000D_
Table 1. Key Players of Peptic Ulcer Drugs in India_x000D_
Table 2. Top Players in India, Ranking by Revenue (2019)_x000D_
Table 3. India Peptic Ulcer Drugs Revenue by Companies, (US$, Mn), 2015-2020_x000D_
Table 4. India Peptic Ulcer Drugs Revenue Share by Companies, 2015-2020_x000D_
Table 5. India Peptic Ulcer Drugs Sales by Companies, (M Unit), 2015-2020_x000D_
Table 6. India Peptic Ulcer Drugs Sales Share by Companies, 2015-2020_x000D_
Table 7. Key Manufacturers Peptic Ulcer Drugs Price (2015-2020) (USD/K Units)_x000D_
Table 8. India Manufacturers Peptic Ulcer Drugs Product Type_x000D_
Table 9. List of India Tier 1 Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 10. List of India Tier 2 and Tier 3 Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2019 and Market Share_x000D_
Table 11. By Type - Peptic Ulcer Drugs Revenue in India (US$, Mn), 2015-2020_x000D_
Table 12. By Type - Peptic Ulcer Drugs Revenue in India (US$, Mn), 2021-2026_x000D_
Table 13. By Type - Peptic Ulcer Drugs Sales in India (M Unit), 2015-2020_x000D_
Table 14. By Type - Peptic Ulcer Drugs Sales in India (M Unit), 2021-2026_x000D_
Table 15. By Application - Peptic Ulcer Drugs Revenue in India, (US$, Mn), 2015-2020_x000D_
Table 16. By Application - Peptic Ulcer Drugs Revenue in India, (US$, Mn), 2021-2026_x000D_
Table 17. By Application - Peptic Ulcer Drugs Sales in India, (M Unit), 2015-2020_x000D_
Table 18. By Application - Peptic Ulcer Drugs Sales in India, (M Unit), 2021-2026_x000D_
Table 19. Takeda Pharmaceutical Corporate Summary_x000D_
Table 20. Takeda Pharmaceutical Peptic Ulcer Drugs Product Offerings_x000D_
Table 21. Takeda Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 22. AstraZeneca Corporate Summary_x000D_
Table 23. AstraZeneca Peptic Ulcer Drugs Product Offerings_x000D_
Table 24. AstraZeneca Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 25. Pfizer Corporate Summary_x000D_
Table 26. Pfizer Peptic Ulcer Drugs Product Offerings_x000D_
Table 27. Pfizer Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 28. Teva Pharmaceuticals Corporate Summary_x000D_
Table 29. Teva Pharmaceuticals Peptic Ulcer Drugs Product Offerings_x000D_
Table 30. Teva Pharmaceuticals Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 31. EA Pharma Corporate Summary_x000D_
Table 32. EA Pharma Peptic Ulcer Drugs Product Offerings_x000D_
Table 33. EA Pharma Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 34. ASK Pharm Corporate Summary_x000D_
Table 35. ASK Pharm Peptic Ulcer Drugs Product Offerings_x000D_
Table 36. ASK Pharm Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 37. Luoxin Pharmaceutical Corporate Summary_x000D_
Table 38. Luoxin Pharmaceutical Peptic Ulcer Drugs Product Offerings_x000D_
Table 39. Luoxin Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 40. Abbott Laboratories Corporate Summary_x000D_
Table 41. Abbott Laboratories Peptic Ulcer Drugs Product Offerings_x000D_
Table 42. Abbott Laboratories Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 43. Yuhan Pharmaceutical Corporate Summary_x000D_
Table 44. Yuhan Pharmaceutical Peptic Ulcer Drugs Product Offerings_x000D_
Table 45. Yuhan Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 46. Daewoong Pharmaceutical Corporate Summary_x000D_
Table 47. Daewoong Pharmaceutical Peptic Ulcer Drugs Product Offerings_x000D_
Table 48. Daewoong Pharmaceutical Peptic Ulcer Drugs Sales (M Unit), Revenue (US$, Mn) and Average Price (USD/K Units) (2015-2020)_x000D_
Table 49. Peptic Ulcer Drugs Production Capacity (M Unit) of Local Manufacturers in India, 2015-2020_x000D_
Table 50. Peptic Ulcer Drugs Production (M Unit) of Local Manufacturers in India, 2015-2020_x000D_
Table 51. India Peptic Ulcer Drugs Production Market Share of Local Manufacturers, 2015-2020_x000D_
Table 52. Peptic Ulcer Drugs Production Value (US$, Mn) of Local Manufacturers in India, 2015-2020_x000D_
Table 53. India Peptic Ulcer Drugs Production Value Market Share of Local Manufacturers, 2015-2020_x000D_
Table 54. The Percentage of Peptic Ulcer Drugs Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 55. The Percentage of Peptic Ulcer Drugs Production Sold in India and Sold Other Than India by Manufacturers_x000D_
Table 56. Dangeguojia Peptic Ulcer Drugs Sales (Consumption), Production, Export and Import, 2015-2020_x000D_
Table 57. Raw Materials and Suppliers_x000D_
Table 58. Peptic Ulcer Drugs Downstream Clients in India_x000D_
Table 59. Peptic Ulcer Drugs Distributors and Sales Agents in India_x000D_
List of Figures_x000D_
Figure 1. Peptic Ulcer Drugs Segment by Type_x000D_
Figure 2. Peptic Ulcer Drugs Segment by Application_x000D_
Figure 3. Dangeguojia Peptic Ulcer Drugs Market Overview: 2020_x000D_
Figure 4. Key Caveats_x000D_
Figure 5. Peptic Ulcer Drugs Market Size in India, (US$, Mn) & (M Unit): 2020 VS 2026_x000D_
Figure 6. India Peptic Ulcer Drugs Revenue, 2015-2026 (US$, Mn)_x000D_
Figure 7. Peptic Ulcer Drugs Sales in India: 2015-2026 (M Unit)_x000D_
Figure 8. The Top 3 and 5 Players Market Share by Peptic Ulcer Drugs Revenue in 2019_x000D_
Figure 9. By Type - India Peptic Ulcer Drugs Incremental Growth, (US$, Mn), 2015-2026_x000D_
Figure 10. By Type - India Peptic Ulcer Drugs Market Share, 2015-2020_x000D_
Figure 11. By Type - India Peptic Ulcer Drugs Market Share, 2020-2026_x000D_
Figure 12. By Type - India Peptic Ulcer Drugs Price (USD/K Units), 2015-2026_x000D_
Figure 13. By Application - Peptic Ulcer Drugs Revenue in India (US$, Mn), 2020 & 2026_x000D_
Figure 14. By Application - India Peptic Ulcer Drugs Market Share, 2015-2020_x000D_
Figure 15. By Application - India Peptic Ulcer Drugs Market Share, 2020-2026_x000D_
Figure 16. By Application -India Peptic Ulcer Drugs Price (USD/K Units), 2015-2026_x000D_
Figure 17. India Peptic Ulcer Drugs Production Capacity (M Unit), 2015-2026_x000D_
Figure 18. India Peptic Ulcer Drugs Actual Output (M Unit), 2015-2026_x000D_
Figure 19. India Peptic Ulcer Drugs Production Value (US$, Mn), 2015-2026_x000D_
Figure 20. The Percentage of India Peptic Ulcer Drugs Export Destination, 2019_x000D_
Figure 21. The Source of Imports of India Peptic Ulcer Drugs, 2019_x000D_
Figure 22. PEST Analysis for India Peptic Ulcer Drugs Market in 2020_x000D_
Figure 23. Peptic Ulcer Drugs Market Opportunities & Trends in India_x000D_
Figure 24. Peptic Ulcer Drugs Market Drivers in India_x000D_
Figure 25. Peptic Ulcer Drugs Market Restraints in India_x000D_
Figure 26. Peptic Ulcer Drugs Industry Value Chain_x000D_

Kindly Fill The Form Below

Report Title: Peptic Ulcer Drugs Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026


Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW